Hofferberth Sophie C, Esch Jesse J, Zurakowski David, Baird Christopher W, Mayer John E, Emani Sitaram M
1Department of Cardiac Surgery,Boston Children's Hospital,Harvard Medical School,Boston,MA,USA.
2Department of Cardiology,Boston Children's Hospital,Harvard Medical School,Boston,MA,USA.
Cardiol Young. 2018 Sep;28(9):1091-1098. doi: 10.1017/S104795111800080X. Epub 2018 Jul 6.
IntroductionThe optimal approach to unifocalisation in pulmonary atresia with ventricular septal defect and major aortopulmonary collateral arteries (pulmonary artery/ventricular septal defect/major aortopulmonary collaterals) remains controversial. Moreover, the impact of collateral vessel disease burden on surgical decision-making and late outcomes remains poorly defined. We investigated our centre's experience in the surgical management of pulmonary artery/ventricular septal defect/major aortopulmonary collaterals.Materials and methodsBetween 1996 and 2015, 84 consecutive patients with pulmonary artery/ventricular septal defect/major aortopulmonary collaterals underwent unifocalisation. In all, 41 patients received single-stage unifocalisation (Group 1) and 43 patients underwent multi-stage repair (Group 2). Preoperative collateral vessel anatomy, branch pulmonary artery reinterventions, ventricular septal defect status, and late right ventricle/left ventricle pressure ratio were evaluated.
Median follow-up was 4.8 compared with 5.7 years for Groups 1 and 2, respectively, p = 0.65. Median number of major aortopulmonary collaterals/patient was 3, ranging from 1 to 8, in Group 1 compared with 4, ranging from 1 to 8, in Group 2, p = 0.09. Group 2 had a higher number of lobar/segmental stenoses within collateral vessels (p = 0.02). Group 1 had fewer catheter-based branch pulmonary artery reinterventions, with 5 (inter-quartile range from 1 to 7) per patient, compared with 9 (inter-quartile range from 4 to 14) in Group 2, p = 0.009. Among patients who achieved ventricular septal defect closure, median right ventricle/left ventricle pressure was 0.48 in Group 1 compared with 0.78 in Group 2, p = 0.03. Overall mortality was 6 (17%) in Group 1 compared with 9 (21%) in Group 2.DiscussionSingle-stage unifocalisation is a promising repair strategy in select patients, achieving low rates of reintervention for branch pulmonary artery restenosis and excellent mid-term haemodynamic outcomes. However, specific anatomic substrates of pulmonary artery/ventricular septal defect/major aortopulmonary collaterals may be better suited to multi-stage repair. Preoperative evaluation of collateral vessel calibre and function may help inform more patient-specific surgical management.
引言
对于合并室间隔缺损及主要体肺侧支动脉的肺动脉闭锁(肺动脉/室间隔缺损/主要体肺侧支)患者,单心室化的最佳方法仍存在争议。此外,侧支血管病变负荷对外科决策及远期预后的影响仍未明确界定。我们调查了本中心在肺动脉/室间隔缺损/主要体肺侧支外科治疗方面的经验。
材料与方法
1996年至2015年期间,84例连续性肺动脉/室间隔缺损/主要体肺侧支患者接受了单心室化手术。其中,41例患者接受了一期单心室化手术(第1组),43例患者接受了分期修复手术(第2组)。评估了术前侧支血管解剖结构、分支肺动脉再次干预情况、室间隔缺损状态及远期右心室/左心室压力比值。
第1组和第2组的中位随访时间分别为4.8年和5.7年,p = 0.65。第1组患者的主要体肺侧支血管中位数为3条(范围1至8条),第2组为4条(范围1至8条),p = 0.09。第2组侧支血管内叶/段狭窄的数量更多(p = 0.02)。第1组基于导管的分支肺动脉再次干预较少,每名患者5次(四分位数间距为1至7次),而第2组为9次(四分位数间距为4至14次),p = 0.009。在室间隔缺损闭合的患者中,第1组的右心室/左心室压力中位数为0.48,第2组为0.78,p = 0.03。第1组的总死亡率为6例(17%),第2组为9例(21%)。
讨论
一期单心室化是部分患者中一种有前景的修复策略,分支肺动脉再狭窄的再次干预率低,中期血流动力学结果良好。然而,肺动脉/室间隔缺损/主要体肺侧支的特定解剖学基础可能更适合分期修复。术前评估侧支血管管径和功能可能有助于制定更具个体化的外科治疗方案。